Trending Now
Don't Miss
Heineken Holding N.V. reports transactions under its current share buyback programme
Heineken Holding N.V. reports transactions under its current share buyback programme Amsterdam, 9 March 2026 - Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports...
Lifestyle News
Heineken Holding N.V. reports transactions under its current share buyback programme
Heineken Holding N.V. reports transactions under its current share buyback programme Amsterdam, 9 March 2026 - Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports...
DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk
Study results were recently shared at the Society of Surgical Oncology (SSO) 2026 Annual Meeting in Phoenix. NCCN Cutaneous Melanoma Guidelines recommend avoiding a...
HOUSE DESIGN
Tech and Gadgets
Heineken Holding N.V. reports transactions under its current share buyback programme
Heineken Holding N.V. reports transactions under its current share buyback programme Amsterdam, 9 March 2026 - Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports...
Make it modern
Latest Reviews
Heineken Holding N.V. reports transactions under its current share buyback programme
Heineken Holding N.V. reports transactions under its current share buyback programme Amsterdam, 9 March 2026 - Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports...
Performance Training
Heineken Holding N.V. reports transactions under its current share buyback programme
Heineken Holding N.V. reports transactions under its current share buyback programme Amsterdam, 9 March 2026 - Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports...
DecisionDx®-Melanoma’s i31-SLNB: Report from the Largest Prospective Multicenter Study to Date Confirms 2.6% Nodal Positivity in Patients Predicted to Have Less Than 5% Risk
Study results were recently shared at the Society of Surgical Oncology (SSO) 2026 Annual Meeting in Phoenix. NCCN Cutaneous Melanoma Guidelines recommend avoiding a...
HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD
Published results have shown 87% clinical response to non-invasive Transcranial Magnetic Stimulation with neuroplastic medications.Clinical leadership by physicians trained at Harvard, Johns Hopkins, Georgetown,...
Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results
SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (Nasdaq: KYNB), formerly FibroGen (Nasdaq: FGEN), will announce fourth quarter and full...
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
Lead candidate, EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, remains on track for IND/CTA submission by mid-2026 Preparing to initiate...
Holiday Recipes
Heineken Holding N.V. reports transactions under its current share buyback programme Amsterdam, 9 March 2026 - Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports...
Recent Comments